Carregant...
Sequencing of systemic treatment for hepatocellular carcinoma: Second line competitors
During the last decades, further knowledge of hepatocellular carcinoma (HCC) molecular mechanisms has led to development of effective systemic treatments including tyrosine kinase inhibitors (TKIs) and immunotherapy. In this review, we describe first and second line systemic treatment options for ad...
Guardat en:
| Publicat a: | World J Gastroenterol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Baishideng Publishing Group Inc
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7201145/ https://ncbi.nlm.nih.gov/pubmed/32390700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v26.i16.1888 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|